LAUREN ARCILLA: Open Payments
NPI 1376013912 · NOKOMIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,208 in 65 payments from 13 companies in 2025. Trend: 2023 $1,008 · 2024 $2,296 · 2025 $1,208
Food & beverage: $1,208
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $455 |
| Amgen Inc. | 18 | $148 |
| PFIZER INC. | 4 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $92 |
| Lilly USA, LLC | 5 | $86 |
| Exact Sciences Corporation | 3 | $75 |
| GlaxoSmithKline, LLC. | 4 | $67 |
| Novo Nordisk Inc | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
Products named: UBRELVY, QULIPTA, VRAYLAR, OTEZLA, XIFAXAN, NURTEC ODT, TRELEGY ELLIPTA, Cologuard Collection Kit.
Industry payments across FL — which companies pay providers there.
